Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents

NCT01341132 is registered in ClinicalTrials.gov with San Francisco Veterans Affairs Medical Center as lead sponsor.

NCT NCT01341132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01341132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents
Lead sponsor
San Francisco Veterans Affairs Medical Center
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2011
Completion date
Not reported
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma